Fabrizio Martelli, Paola Verachi, Maria Zingariello, Maria Mazzarini, Alessandro M Vannucchi, Annalisa Lonetti, Barbara Bacci, Giuseppe Sarli, Anna Rita Migliaccio
Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 4 institutions in 1 country.
Fabrizio MartelliNational Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.
Paola VerachiDepartment of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
Maria ZingarielloUnit of Microscopic and Ultrastructural Anatomy, Department of Medicine, University Campus Bio-Medico, Rome, Italy.
Maria MazzariniDepartment of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
Alessandro M VannucchiDepartment of Clinical and Experimental Medicine, Center of Research and Innovation of Myeloproliferative neoplasms (CRIMM), AOU Careggi, University of Florence, Florence, Italy.
Annalisa LonettiDepartment of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
Barbara BacciDepartment of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Giuseppe SarliDepartment of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Anna Rita MigliaccioMyeloproliferative Neoplasm Research Consortium, New York, NY, United States.
University of Bologna · ITUniversità Campus Bio-Medico · ITIstituto Superiore di Sanità · ITUniversity of Florence · IT
Funding
Tissue BankP01CA108671 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Ronald Hoffman · 2006 to 2026
$82.0M
Generation of cultured RBCs with rare phenotypes for transfusion from sources usually discarded during regular blood donationsR01HL134684 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BIEKER, JAMES J, MIGLIACCIO, ANNA RITA F · 2018 to 2021
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.